[Bronchiolitis obliterans organizing pneumonia induced by chemotherapy].
Aguiar Bujanda
D
D
Aguiar Morales
J
J
Bohn Sarmiento
U
U
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects; D018893:Bronchoalveolar Lavage; D018549:Cryptogenic Organizing Pneumonia / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000009:adverse effects; D016896:Treatment Outcome; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D005938:Glucocorticoids; D003841:Deoxycytidine; D017239:Paclitaxel; D000093542:Gemcitabine